Currently, host response biomarkers used for predicting COVID-19 severity include proinflammatory cytokines (IL6, TNF, IL8, etc.), inflammatory markers (CRP, procalcitonin, and ferritin, etc.), neutrophil/lymphocyte ratio, and lymphopenia (39). The gene discussed is CXCL8; the disease is lymphopenia.